However, hypertensive nephropathy is more common in patients of African origin who carry the APOL1 gene variant, and this can increase the risk of hypertension-related end-stage renal disease by ~ 8 – 10 times. This evidence concerns the gene APOL1 and hypertensive nephropathy.